Form 4: Nancy Andrews Reports Charles River Labs Share Transfer

Nancy C. Andrews, a Director at Charles River Laboratories, reported a transfer of 3,964 common shares to a revocable trust she controls.

Summary

• Nancy C. Andrews, a Director at Charles River Laboratories International, Inc., has filed a Form 4 statement detailing a transaction.
• On May 12, 2026, Ms. Andrews transferred 3,964 shares of common stock.
• This transfer was made to a revocable trust controlled by Ms. Andrews.
• The transaction was conducted under Rule 16a-13, which provides an exemption for certain transfers.
• Following the transaction, Ms. Andrews directly beneficially owns 1,438 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents an internal transfer of shares to a trust and does not indicate a change in beneficial ownership or a sale of stock.

Positives

• The transaction was an exempt transfer, indicating it was a routine or internal reallocation of assets rather than a sale.
• Ms. Andrews retains beneficial ownership of the shares through the revocable trust, suggesting no change in ultimate control.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing indicates a reallocation of shares within the reporting person's control, rather than a disposition of assets.

Related Party Transactions

• Transfer of 3,964 shares of common stock from Nancy C. Andrews to a revocable trust controlled by Nancy C. Andrews.

Stakeholder Impact

• Shareholders: Increased transparency regarding the beneficial ownership of shares held by a director.
• Management: Standard compliance with SEC reporting requirements.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Beneficial Ownership, Charles River Laboratories, Nancy C. Andrews, Revocable Trust, Common Stock, Rule 16a-13